{"title":"[Multiple tumors in patients with laryngeal cancer].","authors":"I Hybásek","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The author evaluated a group of patients treated on account of carcinoma of the larynx in 1958-1977 and followed up till 1988. A second primary tumour except to that of the larynx and skin was detected in 1978 in 5.5% of the patients, in 1983 in 10.0%, and in 1988 in 12.6%. Before the complete extinction of the group due to deaths of its members it may be assumed that multiple tumours will reach 17%. 44% of the multiple tumours were carcinomas of the lungs and 43% carcinomas of the digestive tract. Follow-up of patients after treatment of carcinoma of the larynx must concentrate attention among others also on organs with a high probability of tumour multiplicity.</p>","PeriodicalId":75692,"journal":{"name":"Ceskoslovenska otolaryngologie","volume":"38 5","pages":"273-8"},"PeriodicalIF":0.0000,"publicationDate":"1989-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ceskoslovenska otolaryngologie","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The author evaluated a group of patients treated on account of carcinoma of the larynx in 1958-1977 and followed up till 1988. A second primary tumour except to that of the larynx and skin was detected in 1978 in 5.5% of the patients, in 1983 in 10.0%, and in 1988 in 12.6%. Before the complete extinction of the group due to deaths of its members it may be assumed that multiple tumours will reach 17%. 44% of the multiple tumours were carcinomas of the lungs and 43% carcinomas of the digestive tract. Follow-up of patients after treatment of carcinoma of the larynx must concentrate attention among others also on organs with a high probability of tumour multiplicity.